141 episodios

New research and clinical trials yield frequent developments in neuroscience and mental health. ReachMD welcomes an array of leading thinkers who lend their focused expertise to these principles, central to human function and ability.

Focus on Neurology and Psychiatry ReachMD

    • Ciencia

New research and clinical trials yield frequent developments in neuroscience and mental health. ReachMD welcomes an array of leading thinkers who lend their focused expertise to these principles, central to human function and ability.

    Investigating the Adoption of Behavioral Health Integration

    Investigating the Adoption of Behavioral Health Integration

    Host: Jennifer Caudle, DO

    Guest: Kathleen Blake, MD, MPH

    Guest: Peggy Chen, MD


    Behavioral health integration has proven to be an effective solution to improving access to treatment for many mental health conditions… So why is it not more prevalent in the medical community? Joining Dr. Jennifer Caudle to dive into the findings and implications of the joint AMA-RAND Corporation study recently published in the Annals of Internal Medicine are Dr. Kathleen Blake with the AMA and Dr. Peggy Chen from the RAND Corporation.

    Bipolar Disorder: Pathophysiology and Comorbidities

    Bipolar Disorder: Pathophysiology and Comorbidities

    Guest: Andrew Cutler, MD


    In Chapter 1 of this three-part series that’s designed to help increase the awareness and understanding of the pathophysicology and comorbidities in patients with bipolar disorder or schizophrenia, Dr. Cutler explores the pathophysicology and some comorbidities in patients with bipolar disorder.
    This is an informational non-CME program sponsored by Alkermes, Inc. ALKERMES® is a registered trademark of Alkermes, Inc. KEEP THE BODY IN MIND® is a registered service mark of Alkermes Pharma Ireland Limited, used by Alkermes, Inc., under license. ©2020 Alkermes, Inc. All rights reserved.
    None of the subjects pictured are actual patients.
    UNB-002745

    Schizophrenia: Pathophysiology and Comorbidities

    Schizophrenia: Pathophysiology and Comorbidities

    Guest: Andrew Cutler, MD


    Take a closer look at the pathophysiology of schizophrenia and a range of physical comorbidities with Dr. Cutler in Chapter 2 of this three-part series for the “Keep the Body in Mind” initiative.
    This is an informational non-CME program sponsored by Alkermes, Inc. ALKERMES® is a registered trademark of Alkermes, Inc. KEEP THE BODY IN MIND® is a registered service mark of Alkermes Pharma Ireland Limited, used by Alkermes, Inc., under license. ©2020 Alkermes, Inc. All rights reserved.
    None of the subjects pictured are actual patients.
    UNB-002974

    Opportunities to Manage the Whole Patient with Bipolar Disorder or Schizophrenia

    Opportunities to Manage the Whole Patient with Bipolar Disorder or Schizophrenia

    Guest: Andrew Cutler, MD


    In the third and final chapter of this series for the “Keep the Body in Mind” initiative, Dr. Cutler discusses strategies that could improve care for patients with bipolar disorder or schizophrenia and talks about recommendations for evaluating and monitoring health conditions.
    This is an informational non-CME program sponsored by Alkermes, Inc. ALKERMES® is a registered trademark of Alkermes, Inc. KEEP THE BODY IN MIND® is a registered service mark of Alkermes Pharma Ireland Limited, used by Alkermes, Inc., under license. ©2020 Alkermes, Inc. All rights reserved.
    None of the subjects pictured are actual patients.
    UNB-002975

    Keys to Avoiding an Adrenoleukodystrophy Misdiagnosis

    Keys to Avoiding an Adrenoleukodystrophy Misdiagnosis

    Host: Mario R. Nacinovich, Jr., MSc

    Guest: Paul Orchard, MD


    Although it only affects about one in 18,000 people, the impacts of adrenoleukodystrophy cannot be underestimated. That’s why Dr. Paul Orchard joins Mario Nacinovich to talk about this rare—and fatal—genetic disease, why it’s often underdiagnosed and confused with other conditions, and how we can treat it once we’ve reached an accurate diagnosis.

    Genetic Testing for Psychiatric Disorders: Is It Ready for Primetime?

    Genetic Testing for Psychiatric Disorders: Is It Ready for Primetime?

    Host: Mimi Secor, DNP, FNP-BC, FAANP

    Guest: James B, Potash, MD, MPH


    Psychopharmacology is the study of genetic variations to pinpoint more effective personalized treatments for psychiatric disorders. But with clinicians, industry heads, insurance providers, and regulating agencies all weighing in on this practice and forming varying opinions, what’s the best way to move forward? Here to answer that question and others with Dr. Mimi Secor is Dr. James Potash, a Professor of Psychiatry and Behavioral Sciences and Psychiatrist in Chief at the John Hopkins Department of Psychiatry.

Top podcasts en Ciencia

Otros usuarios también se han suscrito a

Más de ReachMD